Industry News
Researchers block cell division, induce cell death, and overcome tumor resistance to therapy
Sep 27, 2013
A new experimental approach to treating a type of brain cancer called medulloblastoma has been developed by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham). The method targets cancer stem cells - the cells that are critical for maintaining tumor growth - and halts their ability to proliferate by inhibiting enzymes that are essential for tumor progression... Read More
Repurposed antidepressants have potential to treat small-cell lung cancer
Sep 27, 2013
A bioinformatics approach to repurposing drugs resulted in identification of a class of antidepressants as a potential new treatment for small-cell lung cancer (SCLC), according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research. Based on data generated using bioinformatics, two drugs approved by the U.S... Read More
Smoking increases risk of complications, death after colorectal surgery and most common procedures
Sep 27, 2013
Infection, pneumonia, blood clots and kidney failure are all possible complications after any major surgery. A new study shows that smoking boosts the risk of such complications following some of the most common colorectal procedures, including surgery for colon cancer, diverticulitis or inflammatory bowel disease... Read More
Childhood cancer survivors at higher risk of renal failure
Sep 27, 2013
In a new study, adult survivors of childhood cancers who had certain chemotherapy treatments or kidney surgery had worse kidney function that did not recover over time. Researchers say this means they may be at higher risk for premature chronic renal failure... Read More
Study of 'sister' stem cells uncovers new cancer clue
Sep 26, 2013
Scientists have used a brand new technique for examining individual stem cells to uncover dramatic differences in the gene expression levels - which genes are turned 'up' or 'down' - between apparently identical 'sister' pairs. The research, published in Stem Cell Reports, was conducted and funded by The Institute of Cancer Research, London... Read More
Merck Serono announces decision to continue the development of tecemotide in Stage III non-small cell lung cancer
Sep 26, 2013
Merck Serono, the biopharmaceutical division of Merck, has announced the decision to continue clinical development of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) under a new Phase III trial called START2 for patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC)... Read More
Potential to predict lung-cancer spread via MicroRNA-31
Sep 26, 2013
Determining whether a patient's lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that measuring levels of a particular molecule in a sample of tumor tissue might accurately answer the question. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G... Read More
Growing number of young adults with oropharyngeal cancer linked to HPV
Sep 26, 2013
The human papillomavirus (HPV) may be to blame for the alarming increase of young adults with oropharyngeal cancer, according to researchers from Henry Ford Hospital in Detroit. The study reveals an overall 60 percent increase from 1973 and 2009 in cancers of the base of tongue, tonsils, soft palate and pharynx in people younger than age 45... Read More
Merck Serono announces decision to continue the development of tecemotide in Stage III non-small cell lung cancer
Sep 26, 2013
Merck Serono, the biopharmaceutical division of Merck, has announced the decision to continue clinical development of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) under a new Phase III trial called START2 for patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC)... Read More
Research reveals why ibuprofen might stop cancers from developing
Sep 26, 2013
Latest research by scientists at the University of Bath has shown why the anti-inflammatory drug ibuprofen might stop certain cancers from developing... Read More
Previous Page Next Page